TITAN PHARMACEUTICALS & DESIGN

Class [005]
Pharmaceuticals, namely, treatment for central nervous disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, Parkinson's disease, restless leg syndrome, opioid use disorder, chronic pain and cancer, hematological disorders, endocrine disorders, namely, growth and thyroid disorders, and cancer, metabolic disorders, namely, obesity, hyperlipidemia, diabetes, and hypertension, inflammatory disorders, namely, inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, arthritis and rheumatoid arthritis, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, namely, cancer, atherosclerosis, stroke, anemia, heart attack, congestive heart failure, hypertension, intestinal disorders, namely, gastro-intestinal diseases, and cancer, bone disease, autoimmune disorders and disorders of the immune systems, infectious diseases, namely, respiratory infections, eye infections, topical infections, malaria, parasitic infections, bacterial infections, viral infections and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, Parkinson's disease, restless leg syndrome, opioid use disorder, chronic pain and cancer and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, namely, growth and thyroid disorders, and cancer, metabolic disorders, namely, obesity, hyperlipidemia, diabetes, and hypertension, inflammatory disorders, namely, inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, arthritis and rheumatoid arthritis, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, namely, cancer, atherosclerosis, stroke, anemia, heart attack, congestive heart failure, hypertension, intestinal disorders, namely, gastro-intestinal diseases, and cancer, bone disease, autoimmune disorders and disorders of the immune systems, infectious diseases, namely, respiratory infections, eye infections, topical infections, malaria, parasitic infections, bacterial infections, viral infections and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymerbased matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases.